Search form

Lionsgate Loses A Battle to Icahn

In the war between shareholder Carl Icahn and Lionsgate, the studio lost a round when Canadian regulators rejected their poison pill option, reports VARIETY.

In the war between shareholder Carl Icahn and Lionsgate, the studio lost a round when Canadian regulators rejected their poison pill option, reports VARIETY. The move would have diluted Icahn's shares if he obtains a 20% stake or higher. The British Columbia Securities Commission did not give reasons for its decision.

Icahn currently controls 19% of Lionsgate and has made a $7 per share offer to take over the company. The shareholder is upset with the way Lionsgate is handling financial decisions.

Rick DeMott's picture

Rick DeMott
Animation World Network
Creator of Rick's Flicks Picks

randomness